IP Library Assignment 067171/0968
Patent Assignment
Reel/Frame 067171/0968

Patent Security Agreement

Recorded: 2024-04-19 Pages: 7
Assignor
TARSUS PHARMACEUTICALS, INC.
Executed: 2024-04-19
Assignee
BIOPHARMA CREDIT PLC
C/O BEAUFORT HOUSE, 51 NEW NORTH ROAD, EXETER, EX4 4EP, UNITED KINGDOM
Covered Properties (13)
Isoxazoline Parasiticide Formulations and Methods for Treating Blepharitis
Application: 17/099,531 →
Publication: US 2021/0077465
Isoxazoline Parasiticide Formulations and Methods for Treating Blepharitis
Application: 18/325,919 →
Publication: US 2023/0293496
Isoxazoline Parasiticide Formulations
Application: 18/325,910 →
Publication: US 2023/0301971
Methods for Treating Ocular Demodex Using Spinosad Formulations
Application: 18/169,553 →
Publication: US 2023/0190711
Pharmaceutical Compositions for Demodex Related Blepharitis and Eyelid Crusting
Application: 17/570,745 →
Publication: US 2022/0125817
Systemic Isoxazoline Parasiticides for Vector-Borne and Viral Disease Treatment or Prophylaxis
Application: 17/594,144 →
Publication: US 2022/0160682
Systemic Isoxazoline Parasiticides for Vector-Borne and Viral Disease Treatment or Prophylaxis
Application: 18/184,513 →
Publication: US 2023/0218584
Isoxazoline Parasiticide Formulations and Methods for Treating Blepharitis
Application: 17/620,095 →
Publication: US 2022/0249445
Methods for Treating Ocular Demodex Using Isoxazoline Parasiticide Formulations
Application: 16/221,390 →
Publication: US 2019/0183862
Isoxazoline Parasiticide Formulations and Methods for Treating Ocular Demodex Infestation
Application: 17/193,453 →
Publication: US 2021/0196689
Methods for Treating Ocular Demodex Using Lotilaner Formulations
Application: 17/873,548 →
Publication: US 2022/0362218
Methods for Treating Demodex Blepharitis Using Lotilaner Formulations
Application: 17/873,540 →
Publication: US 2022/0354829
Ophthalmic Compositions for Treating Ocular Demodex Using Lotilaner Formulations
Application: 17/873,698 →
Publication: US 2022/0354830
Related Assignments (10)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 24, 2019
From: AZAMIAN, BOBAK ROBERT; ACKERMANN, DOUGLAS MICHAEL; HICKOK, SHAWN D.; VEHIGE, JOSEPH G.
To: TARSUS PHARMACEUTICALS, INC.
Reel/Frame 049565/0184 →
Assignment of Assignor's Interest Oct 28, 2021
From: AZAMIAN, BOBAK ROBERT; ACKERMANN, DOUGLAS MICHAEL; HICKOK, SHAWN D.; VEHIGE, JOSEPH G.
To: TARSUS PHARMACEUTICALS, INC.
Reel/Frame 057947/0961 →
Assignment of Assignor's Interest Oct 28, 2021
From: AZAMIAN, BOBAK ROBERT; ACKERMANN, DOUGLAS MICHAEL; HICKOK, SHAWN D.; VEHIGE, JOSEPH G.
To: TARSUS PHARMACEUTICALS, INC.
Reel/Frame 057947/0240 →
Assignment of Assignor's Interest Oct 28, 2021
From: AZAMIAN, BOBAK ROBERT; ACKERMANN, DOUGLAS MICHAEL; HICKOK, SHAWN D.; STIVERS, CHRISTOPHER
To: TARSUS PHARMACEUTICALS, INC.
Reel/Frame 057948/0898 →
Assignment of Assignor's Interest Mar 16, 2022
From: JERRY TAN EYE SURGERY PTE LTD
To: TARSUS PHARMACEUTICALS, INC.
Reel/Frame 059287/0180 →
Assignment of Assignor's Interest Mar 16, 2022
From: TAN, TIANG HIN JERRY; POR, YONG MING
To: JERRY TAN EYE SURGERY PTE LTD
Reel/Frame 059286/0275 →
Assignment of Assignor's Interest Apr 24, 2023
From: AZAMIAN, BOBAK ROBERT; ACKERMANN, DOUGLAS MICHAEL; HICKOK, SHAWN D.; VEHIGE, JOSEPH G.
To: TARSUS PHARMACEUTICALS, INC.
Reel/Frame 063421/0216 →
Assignment of Assignor's Interest Jul 28, 2023
From: AZAMIAN, BOBAK ROBERT; ACKERMANN, DOUGLAS MICHAEL; HICKOK, SHAWN D.; STIVERS, CHRISTOPHER
To: TARSUS PHARMACEUTICALS, INC.
Reel/Frame 064425/0909 →
Assignment of Assignor's Interest Jul 28, 2023
From: AZAMIAN, BOBAK ROBERT; ACKERMANN, DOUGLAS MICHAEL; HICKOK, SHAWN D.; VEHIGE, JOSEPH G.
To: TARSUS PHARMACEUTICALS, INC.
Reel/Frame 064425/0852 →
Assignment of Assignor's Interest Jul 28, 2023
From: AZAMIAN, BOBAK ROBERT; ACKERMANN, DOUGLAS MICHAEL; HICKOK, SHAWN D.; VEHIGE, JOSEPH G.
To: TARSUS PHARMACEUTICALS, INC.
Reel/Frame 064426/0024 →